4th Nov 2022 07:00
4 November 2022
Ondine Biomedical Inc. ("Ondine Biomedical", "Ondine" or the "Company")
PDMR Dealing
Ondine Biomedical Inc. (AIM: OBI), announces the following dealings a person discharging managerial responsibilities ('PDMR'):
On 2 November 2022, Vipul Shah, Chief Financial Officer of Ondine, purchased 15,000 ordinary shares with no par value at a price of 24.5 pence per share. Following this purchase, Mr Shah's total interest in the Company is 65,000 Ordinary Shares, representing 0.033% of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulations, provides further detail in respect of the transaction as described above.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Vipul Shah | ||||
2. | Reason for the Notification | |||||
a) | Position/status | Chief Financial Officer | ||||
b) | Initial notification/amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ondine Biomedical Inc. | ||||
b) | LEI | 9845005B69E07CGF4A56 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted | |||||
a) | Description of the Financial instrument, type of instrument | Ordinary Shares of no par value | ||||
Identification code | GB00BYX5K988 | |||||
b) | Nature of the Transaction | Purchase of ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | As above
| ||||
e) | Date of the transaction | 2.11.2022 | ||||
f) | Place of the transaction | AIM (LSE) | ||||
For further Information, please visit: www.ondinebio.com or contact:
Ondine Biomedical Inc. |
|
Carolyn Cross, CEO | +1 604 669 0555 |
|
|
Strand Hanson Limited (Nominated and Financial Adviser) |
|
James Harris, James Dance, Richard Johnson | +44 (0) 20 7409 3494 |
|
|
RBC Capital Markets (Joint Broker) |
|
Rupert Walford, Kathryn Deegan | +44 (0) 20 7653 4000 |
| |
Singer Capital Markets (Joint Broker) |
|
Aubrey Powell, Asha Chotai | +44 (0)20 7496 3000 |
Vane Percy & Roberts (Media Contact) | |
Simon Vane Percy, Amanda Bernard | +44 (0) 77 1000 5910 |
Related Shares:
Ondine Biomed